Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2X2 Phase III Open-label Clinical Trial of Therapy for Patients With Recurrent Methicillin Resistant Staphylococcus Aureus Infections: Topical Nasal & Body Decolonization and/or Environmental Decontamination vs. Standard of Care

NCT00560599 is registered in ClinicalTrials.gov with loren g miller as lead sponsor.

NCT NCT00560599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00560599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2X2 Phase III Open-label Clinical Trial of Therapy for Patients With Recurrent Methicillin Resistant Staphylococcus Aureus Infections: Topical Nasal & Body Decolonization and/or Environmental Decontamination vs. Standard of Care
Lead sponsor
loren g miller
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2007
Completion date
December 31, 2012
Enrollment
350 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

methicillin resistant staphylococcus aureus skin infections